12 Participants Needed

Fasting-Refedding Cycle for Obesity

(DIP Trial)

ER
RF
Overseen ByRodrigo Fernandez-Verdejo, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Pennington Biomedical Research Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The regulation of human body weight and fatness is not fully understood. Although some models of regulation have been proposed (set point, dual-intervention point, others), no studies have been designed to test their predictions. In this pilot and feasibility study, the investigators will implement an experimental approach to test the predictions of models of body weight regulation in humans. Men and women with either low body weight or obesity will be exposed to a 2-day fasting followed by a 2-day ad-libitum refeeding. During the entire fasting-refeeding period, energy intake and expenditure will be accurately measured within metabolic chambers. The investigators will therefore determine the compensatory responses to fasting elicited to prevent weight loss. The results will serve to design and power future studies to better understand body weight regulation.

Will I have to stop taking my current medications?

You may need to stop taking certain medications that affect energy intake or expenditure, like semaglutide or metformin, to participate in this trial. The protocol doesn't specify a washout period, but it's best to discuss with the trial team.

What data supports the effectiveness of the fasting-refeeding cycle treatment for obesity?

Research shows that alternate day modified fasting can effectively help with weight loss in obese adults. Additionally, a study found that a longer refeeding period after a very-low-energy diet helps maintain weight loss better over a year.12345

Is the fasting-refeeding cycle generally safe for humans?

The studies reviewed do not directly address the safety of fasting-refeeding cycles in humans, but they suggest that refeeding after fasting can help maintain weight loss and improve eating behavior. However, the long-term effects and safety in humans are not clearly established, and more research is needed to understand potential risks.56789

How does the fasting-refeeding cycle treatment for obesity differ from other treatments?

The fasting-refeeding cycle treatment for obesity is unique because it involves alternating periods of fasting and eating freely, which can lead to increased food efficiency and rapid weight regain due to the body's energy conservation mechanisms. This approach contrasts with continuous caloric restriction, which often leads to long-term weight regain due to hormonal and metabolic changes.168910

Research Team

RF

Rodrigo Fernandez-Verdejo, PhD

Principal Investigator

Pennington Biomedical Research Center

ER

Eric Ravussin, PhD

Principal Investigator

Pennington Biomedical Research Center

DL

Dragana Lovre, MD

Principal Investigator

Tulane University

Eligibility Criteria

This trial is for men and women aged 20-40 with stable body weight who are either underweight (BMI < 18.5) or obese (BMI ≥ 30). Participants must have normal thyroid, blood count, and chemistry levels, enjoy Ensure Plus drinks to some extent, and women should not have given birth and must have regular menstrual cycles.

Inclusion Criteria

My BMI is either below 18.5 or above 30.
I am between 20 and 40 years old.
My blood tests for thyroid, blood count, and chemistry are normal.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Inpatient Energy Balance

Participants are maintained in metabolic chambers for 1 day of energy balance

1 day
Inpatient stay

Fasting

Participants undergo 2 days of fasting to measure compensatory responses

2 days
Inpatient stay

Ad-libitum Refeeding

Participants undergo 2 days of ad-libitum refeeding to measure compensatory responses

2 days
Inpatient stay

Follow-up

Participants are monitored for safety and effectiveness after the fasting-refeeding cycle

1-2 weeks

Treatment Details

Interventions

  • Fasting-refeeding cycle
Trial Overview The study tests how the human body regulates weight by having participants go through a fasting-refeeding cycle: two days of fasting followed by two days where they can eat as much as they want. Their energy intake and expenditure will be measured in metabolic chambers.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Fasting-refeeding cycleExperimental Treatment1 Intervention
Participants will be maintained in metabolic chambers and exposed to 1 day of energy balance, 2 days of fasting, and 2 days of ad-libitum refeeding.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Pennington Biomedical Research Center

Lead Sponsor

Trials
314
Recruited
183,000+

Tulane University

Collaborator

Trials
129
Recruited
259,000+

Findings from Research

In a 10-week study with 16 obese participants, alternate day modified fasting (ADMF) led to an average weight loss of 5.6 kg, demonstrating its effectiveness as a weight loss strategy.
Participants adapted well to ADMF, with significant reductions in energy intake on fasting days and no increase in hunger, while maintaining physical activity levels, suggesting that dietary and activity adaptations contribute to the weight loss observed.
Dietary and physical activity adaptations to alternate day modified fasting: implications for optimal weight loss.Klempel, MC., Bhutani, S., Fitzgibbon, M., et al.[2021]
In a study of 38 adults with severe obesity, one cycle of intentional weight loss and regain did not lead to significant negative effects on physical health measures, including weight, body composition, or cardiovascular risk factors.
The findings suggest that weight cycling may not have detrimental physical or psychological consequences, indicating that concerns about weight regain should not deter patients from pursuing weight loss efforts.
Weight cycling in adults with severe obesity: A longitudinal study.El Ghoch, M., Calugi, S., Dalle Grave, R.[2019]
A study of 66 severely obese outpatients on a very low calorie diet (VLCD) for a median of 55 days showed significant improvements in body weight, blood pressure, triglycerides, and cholesterol levels.
Participants with a history of weight cycling experienced less benefit from the VLCD, suggesting that more intensive maintenance strategies may be needed for those individuals to achieve optimal health outcomes.
Weight loss and biomedical health improvement on a very low calorie diet: the moderating role of history of weight cycling.Hart, KE., Warriner, EM.[2016]

References

Dietary and physical activity adaptations to alternate day modified fasting: implications for optimal weight loss. [2021]
Weight cycling in adults with severe obesity: A longitudinal study. [2019]
Weight loss and biomedical health improvement on a very low calorie diet: the moderating role of history of weight cycling. [2016]
Retrospective long-term comparison of naturopathic fasting therapy and weight reduction diet in overweight patients. [2021]
Prolonged refeeding improves weight maintenance after weight loss with very-low-energy diets. [2021]
Refeeding after fasting in the rat: effects on body composition and food efficiency. [2018]
Rationale for novel intermittent dieting strategies to attenuate adaptive responses to energy restriction. [2019]
Body mass cycling and predictors of body mass regain and its impact on cardiometabolic health. [2021]
Plasticity of adipose tissue in response to fasting and refeeding in male mice. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Fatty acid oxidation and fatty acid synthesis in energy restricted rats(1). [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security